FIELD: medicine.
SUBSTANCE: it is necessary to affect gastric and duodenal mucosa with He-Ne laser, at power being about 3-10 mW, time of impact ranges 3-7 min. As a photosensitizer one should apply methylene blue at the dosage of about 5-7 ml 1%-solution. The innovation provides pronounced development of granulation tissue, activation of proliferative processes in surface and glandular epithelium, rapid reconstruction of mucopolysaccharides content in surface-foveolar epithelium, improved values of mucosal microcirculation and the absence of Helicobacter pylori in irradiation area.
EFFECT: higher efficiency.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ACTIVE OXYGEN CONTENT DETECTION ACCOMPANYING Helicobacter pylori INFECTION | 2007 |
|
RU2325653C1 |
| METHOD FOR ERADICATION OF HELICOBACTER PYLORI INFECTION IN STOMACH AND DUODENUM | 2004 |
|
RU2285534C2 |
| METHOD FOR TREATMENT OF HELICOBACTER-ASSOCIATED STOMACH AND DUODENUM INTESTINE ULCEROUS DISEASE | 2004 |
|
RU2278685C1 |
| COMPLEX THERAPY METHOD FOR TREATING DUODENAL PEPTIC ULCER DISEASES ASSOCIATED WITH HELICOBACTER PYLORI | 2006 |
|
RU2318514C2 |
| PHARMACEUTICAL COMPOSITION OF PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATING GASTRIC AND DUODENAL ULCERS | 2009 |
|
RU2410100C2 |
| METHOD OF TREATING ACID-DEPENDENT CONDITIONS ASSOCIATED WITH HELICOBACTER PYLORI | 2011 |
|
RU2446797C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF STOMACH- OR DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI | 2003 |
|
RU2269132C2 |
| METHOD TO TREAT ULCEROUS DUODENAL DISEASE | 2000 |
|
RU2184558C2 |
| METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
| METHOD FOR TREATING INFLAMMATORY DEGENERATIVE STOMACH AND DUODENUM DISEASES | 2005 |
|
RU2289448C1 |
